MORETTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 12.057
EU - Europa 9.221
AS - Asia 2.312
OC - Oceania 167
AF - Africa 125
SA - Sud America 87
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.979
Nazione #
US - Stati Uniti d'America 12.014
PL - Polonia 3.403
RU - Federazione Russa 2.421
IE - Irlanda 897
SE - Svezia 838
SG - Singapore 812
HK - Hong Kong 704
IT - Italia 523
UA - Ucraina 292
FI - Finlandia 282
DE - Germania 270
CN - Cina 209
IN - India 207
AU - Australia 165
GB - Regno Unito 154
TR - Turchia 141
CI - Costa d'Avorio 91
JO - Giordania 85
BR - Brasile 79
VN - Vietnam 57
FR - Francia 42
CA - Canada 36
ID - Indonesia 34
ES - Italia 28
NL - Olanda 18
CH - Svizzera 17
EG - Egitto 16
SC - Seychelles 14
TH - Thailandia 11
EU - Europa 10
BE - Belgio 8
RO - Romania 8
IR - Iran 7
KR - Corea 7
MX - Messico 5
HU - Ungheria 4
KW - Kuwait 4
UZ - Uzbekistan 4
AR - Argentina 3
AZ - Azerbaigian 3
IQ - Iraq 3
JP - Giappone 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CM - Camerun 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
MA - Marocco 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 23.979
Città #
Warsaw 3.400
Santa Clara 2.886
Fairfield 1.284
Chandler 957
Dublin 897
Ashburn 674
Cambridge 540
Woodbridge 516
Jacksonville 495
Seattle 474
Hong Kong 469
Houston 453
Wilmington 443
Singapore 407
Princeton 283
Boston 219
Ann Arbor 199
Mumbai 195
Melbourne 163
Boardman 150
Izmir 134
Beijing 103
Altamura 96
Medford 93
Abidjan 91
Florence 91
Lawrence 91
Buffalo 89
San Diego 85
Moscow 56
Norwalk 49
Shanghai 47
New York 42
Dong Ket 36
Andover 33
Washington 33
Jakarta 31
Hillsboro 29
Toronto 29
Bremen 24
Rome 24
Barcelona 23
Falls Church 22
Helsinki 21
Frankfurt Am Main 19
Los Angeles 18
Phoenix 18
Kent 15
Milan 15
The Dalles 14
Bern 11
Yubileyny 11
Verona 9
Munich 8
Redmond 8
Brussels 7
Falkenstein 7
Fuzhou 7
Guangzhou 7
London 7
Cairo 6
Redwood City 6
Seoul 6
West Jordan 6
Auburn Hills 5
Dearborn 5
Massa E Cozzile 5
Old Bridge 5
Brooklyn 4
Budapest 4
Kuwait 4
Lyon 4
Messina 4
Mestre 4
Mirandola 4
Montréal 4
Rio de Janeiro 4
Torino 4
Baku 3
Brasília 3
Frankfurt am Main 3
Laurel 3
Makassar 3
Naaldwijk 3
Poços de Caldas 3
Prato 3
Pune 3
Saint Petersburg 3
São Paulo 3
Trumbull 3
Acapulco de Juárez 2
Amsterdam 2
Ankara 2
Ariano Irpino 2
Baghdad 2
Bangkok 2
Bani Suwayf 2
Bengaluru 2
Bratislava 2
Camerota 2
Totale 16.797
Nome #
Efficacy of Rhodamine Light in the Treatment of Superficial Vascular Lesions of the Face 291
Nonconventional Use of Flash-Lamp Pulsed-Dye Laser in Dermatology 291
Hair and Scalp Disorders in a Tuscan Pediatric Dermatological Outpatient Clinic: A Clinical and Epidemiological Evaluation 273
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment 272
Primary cutaneous follicular centre- cell lymphoma- a lymphoproliferative disease with favourable prognosis. 264
Potential Infectious Etiology of Behçet's Disease 264
LANGERHANS CELLS AND MYCOSIS FUNGOIDES-A CRITICAL OVERVIEW OF THEIR PATHOGENIC ROLE IN THE DISEASE 263
B-cell lymphoma with secondary cutaneous involvement: an immunohistochemical and ultrastructural study 259
Antigenic phenotype of radial growth phase melanomas with or without a vertical growth phase portion. 258
A peculiar case of linear IgA bullous dermatosis. 252
Stress as a possible mechanism in melanoma progression 248
No Association between Vitiligo and Obesity: A Case-Control Study. 243
Non-lymphoid accessory cells in the cutaneous infiltrate of B cell lymphomas. An immunohistochemical and ultrastructural study 241
STEM CELL FACTOR AFFECTS TUMOUR PROGRESSION MARKERS IN METASTATIC MELANOMA CEELS 240
Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study. 233
Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening. 232
Conventional and unconventional use of lasers in skin disorders 231
Multiple marker studies on a malignant fibrous hystiocytoma with primary cutaneous localization. 225
Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases. 223
Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic and immunologic correlations. 221
Can environmental factors contribute in triggering vitiligo and associated autoimmune thyroid diseases? Clinical series possibly related to the Chernobyl nuclear accident. 217
Plaque-type parapsoriasis and mycosis fungoides: An unclear relationship 216
Treatment of recurrent pilonidal cysts with nd-YAG laser: report of our experience 202
Interessamento cutaneo in corso di leucemia mielo-monocitica 199
Cellule di Sézary: attività immunologiche " in vitro" ed effetto della timostimulina 187
Highlights of thirty years experience of CO2 laser use at the Florence (Italy) Department of Dermatology 186
Lichen planus and liver diseases: a multicentre case- control study. 173
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 163
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants 155
A 2-Month-Old Boy with Desquamative Skin Fold Dermatitis 154
Are Langerhans cells usual components of the dermal infiltrate of mycosis fungoides? 150
Multiple clustered nodules on the leg. 147
Thyroid disorders in vitiligo patients. 146
The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR. 144
Increased oxidative DNA damage in mononuclear leukocytes in vitiligo 140
A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? 134
Oral carcinoma in a young man: a case of dyskeratosis congenita. 133
Polycystic ovary syndrome and vitiligo: simple association or tight connection? 133
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 132
Vitiligo: new and emerging treatments. 129
If herpes does not heal … change strategy! 129
Lesioni pigmentate vulvari 129
Molecular detection of microsatellite instability in basal cell carcinoma. 128
Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin 128
Autoimmune signals in non-segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures. 124
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. 123
Non-segmental vitiligo and psoriasis comorbidity - a case-control study in Italian patients 123
Pediatric pigmented Spitz nevus: A natural course toward involution assessed with dermoscopy 123
Seasonal variations of DNA damage in human lymphocytes: correlation with different environmental variables 122
A case of angiosarcoma of the face successfully treated with combined chemotherapy and radiotherapy. 121
Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients. 121
Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. 119
Mast cells do not play a role in vitiligo 119
Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E and carotenoids in vitiligo treatment 119
Dendritic cells in the dermal infiltrate of Sézary syndrome 119
Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients 119
Primary cutaneous follicular center cell lymphoma: clinical and histological aspects. 118
Cutaneous sarcoid-like granulomas in a patient with x-linked hyper-IgM syndrome 115
Commentary from the Editorial Board to Vitiligo: interplay between oxidative stress and immune system (Laddha et al.). 115
The prognostic significance of histologic regression in cutaneous melanoma. 112
Dermatosis Papulosa Nigra and 10,600-nm CO2 laser, a good choice. 112
Autoimmune polyglandular type IIIc syndrome associated with Vogt-Koyanagi-Harada syndrome and common variable immunodeficiency 112
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 112
In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. 112
Drug consumption and melanocytic nevi: correlation between oral contraceptives or hormone replacement therapy and a high melanocytic nevi count 112
The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options 111
Early diagnosis for melanoma: is open access to skin cancer clinics really significant? A prospective study. 111
Koebner's phenomenon in vitiligo: European position paper 109
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 109
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. 108
Pseudoepitheliomatous hyperplasia in a tattoo 107
Arachidonate transforming and immunomodulating agents; unapproved usual indications. 107
ROS-challenged keratinocytes as a new model for oxidative stress-mediated skin diseases 107
Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists 106
A case of photoallergic contact dermatitis caused by unusual exposure to ketoprofen 104
Ki-67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions. 102
Sequential effects of photodynamic treatment of basal cell carcinoma 102
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force 101
Milia-like idiopathic calcinosis cutis in the absence of Down's syndrome. 101
Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting 101
A multiparametric approach is essential to define different clinicopathological entities within pseudopelade of Brocq: replay from authors 100
Phenotypic and functional characterization of a Sézary cell 99
Angiogenesis of cutaneous melanoma 99
Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. 99
Persistent herpes gestationis 98
Serum imbalance of cytokines in melanoma patients 98
Vitiligo: an update on current pharmacotherapy and future directions 98
HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression. 98
Superficial spreading melanoma with a nodular area: antigenic phenotype of the radial and vertical growth areas. 97
Ocular "non scarring" mucous membrane pemphigoid associated with anti-laminin 5 antibodies 97
Inflammatory linear verrucous epidermal nevus: why a combined laser therapy 96
Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. 95
Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma. 95
Adhesion molecule expression in human melanocytic lesions 95
Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment? 95
Adhesion molecules expression and melanoma progression 94
Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. 94
Autoimmune thyroid disease in Italian patients with non-segmental vitiligo 93
Incidence of toxic epidermal necrolysis in Italy 92
Jessner-Kanof disease:two effective and sure therapeutic options 92
Totale 14.760
Categoria #
all - tutte 60.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020867 0 0 0 0 0 0 0 0 311 208 284 64
2020/20212.532 235 195 169 220 126 379 97 221 225 346 144 175
2021/20221.456 35 201 44 65 48 59 37 80 63 64 218 542
2022/20233.631 455 304 140 294 365 758 486 222 416 14 133 44
2023/20241.242 62 186 308 82 99 211 42 143 8 23 43 35
2024/20257.793 304 1.035 738 1.272 2.656 1.009 93 443 243 0 0 0
Totale 24.083